Investigation of Maintaining Visual Performance Achieved With Cyclosporine Therapy

NCT02121847 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Dry Eye Syndromes

Interventions

DRUG: cyclosporine 0.05% ophthalmic emulsion
DRUG: carboxymethylcellulose-based lubricant eye drops

Sponsor

Allergan